EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Impact of Pharmacogenomics in Clinical Practice

Nicola Principi iD, Kyriakoula Petropulacos, Susanna Esposito iD

Pharmaceuticals · 13.11.2023 · 16 (11) · 1596

DOI: 10.3390/ph16111596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 13.11.2023. Verfasst von Nicola Principi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Milano, 20122 Milan, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymorphisms of genes encoding drug metabolizing enzymes and transporters can significantly modify pharmacokinetics, and this can be associated with significant differences in drug efficacy, safety, and tolerability. Moreover, genetic variants of some components of the immune system can explain clinically relevant drug-related adverse events. However, the implementation of drug dose individualization based on pharmacogenomics remains scarce. In this narrative review, the impact of genetic variations on the disposition, safety, and tolerability of the most commonly prescribed drugs is reported. Moreover, reasons for poor implementation of pharmacogenomics in everyday clinical settings are discussed. The literature analysis showed that knowledge of how genetic variations can modify the effectiveness, safety, and tolerability of a drug can lead to the adjustment of usually recommended drug dosages, improve effectiveness, and reduce drug-related adverse events. Despite some efforts to introduce pharmacogenomics in clinical practice, presently very few centers routinely use genetic tests as a guide for drug prescription. The education of health care professionals seems critical to keep pace with the rapidly evolving field of pharmacogenomics. Moreover, multimodal algorithms that incorporate both clinical and genetic factors in drug prescribing could significantly help in this regard. Obviously, further studies which definitively establish which genetic variations play a role in conditioning drug effectiveness and safety are needed. Many problems must be solved, but the advantages for human health fully justify all the efforts.

Schlagwörter

Stichwörter der Autor:innen

drug prescriptiondrug-related adverse eventsgenetic variantspharmacogenomicspharmacokinetics

Autor:innen und Institutionen

  • University of Milano, 20122 Milan, Italy.
  • Amici del Bambino Malato ODV, 41121 Modena, Italy.
  • Pediatric Clinic, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.

ORCID-Profile: Nicola Principi, Susanna Esposito

Zitieren

APA

Principi, N., Petropulacos, K., & Esposito, S. (2023). Impact of Pharmacogenomics in Clinical Practice. Pharmaceuticals, 16(11), 1596. https://doi.org/10.3390/ph16111596

Vancouver

Principi N, Petropulacos K, Esposito S. Impact of Pharmacogenomics in Clinical Practice. Pharmaceuticals. 2023;16(11):1596. doi:10.3390/ph16111596

BibTeX
@article{Principi2023,
  author = {Principi, Nicola and Petropulacos, Kyriakoula and Esposito, Susanna},
  title = {Impact of Pharmacogenomics in Clinical Practice},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {11},
  pages = {1596},
  doi = {10.3390/ph16111596}
}
Kostenlos starten →